Literature DB >> 28850853

Quantitative genetic analysis of anxiety trait in bipolar disorder.

J Contreras1, E Hare2, G Chavarría3, H Raventós4.   

Abstract

BACKGROUND: Bipolar disorder type I (BPI) affects approximately 1% of the world population. Although genetic influences on bipolar disorder are well established, identification of genes that predispose to the illness has been difficult. Most genetic studies are based on categorical diagnosis. One strategy to overcome this obstacle is the use of quantitative endophenotypes, as has been done for other medical disorders.
METHODS: We studied 619 individuals, 568 participants from 61 extended families and 51 unrelated healthy controls. The sample was 55% female and had a mean age of 43.25 (SD 13.90; range 18-78). Heritability and genetic correlation of the trait scale from the Anxiety State and Trait Inventory (STAI) was computed by using the general linear model (SOLAR package software).
RESULTS: we observed that anxiety trait meets the following criteria for an endophenotype of bipolar disorder type I (BPI): 1) association with BPI (individuals with BPI showed the highest trait score (F = 15.20 [5,24], p = 0.009), 2) state-independence confirmed after conducting a test-retest in 321 subjects, 3) co-segregation within families 4) heritability of 0.70 (SE: 0.060), p = 2.33 × 10-14 and 5) genetic correlation with BPI was 0.20, (SE = 0.17, p = 3.12 × 10-5). LIMITATIONS: Confounding factors such as comorbid disorders and pharmacological treatment could affect the clinical relationship between BPI and anxiety trait. Further research is needed to evaluate if anxiety traits are specially related to BPI in comparison with other traits such as anger, attention or response inhibition deficit, pathological impulsivity or low self-directedness.
CONCLUSIONS: Anxiety trait is a heritable phenotype that follows a normal distribution when measured not only in subjects with BPI but also in unrelated healthy controls. It could be used as an endophenotype in BPI for the identification of genomic regions with susceptibility genes for this disorder. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety; Bipolar disorder; Central Valley of Costa Rica; Endophenotype; Genetics; Heritability

Mesh:

Year:  2017        PMID: 28850853      PMCID: PMC5626643          DOI: 10.1016/j.jad.2017.08.023

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   6.533


  22 in total

1.  Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis.

Authors:  Janet Wozniak; Joseph Biederman; Michael C Monuteaux; Jennifer Richards; Stephen V Faraone
Journal:  J Child Adolesc Psychopharmacol       Date:  2002       Impact factor: 2.576

2.  The Lifetime Dimensions of Psychosis Scale (LDPS): description and interrater reliability.

Authors:  Douglas F Levinson; Bryan J Mowry; Michael A Escamilla; Stephen V Faraone
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

3.  Best estimate of lifetime psychiatric diagnosis: a methodological study.

Authors:  J F Leckman; D Sholomskas; W D Thompson; A Belanger; M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1982-08

4.  Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.

Authors:  S L McElroy; L L Altshuler; T Suppes; P E Keck; M A Frye; K D Denicoff; W A Nolen; R W Kupka; G S Leverich; J R Rochussen; A J Rush; R M Post
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

Review 5.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

Review 6.  Toward constructing an endophenotype strategy for bipolar disorders.

Authors:  Gregor Hasler; Wayne C Drevets; Todd D Gould; Irving I Gottesman; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2006-01-09       Impact factor: 13.382

Review 7.  Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics.

Authors:  David C Glahn; Emma E M Knowles; D Reese McKay; Emma Sprooten; Henriette Raventós; John Blangero; Irving I Gottesman; Laura Almasy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-01-24       Impact factor: 3.568

8.  Only half of bipolar I and II patients report prodromal symptoms.

Authors:  Outi Mantere; Kirsi Suominen; Hanna M Valtonen; Petri Arvilommi; Erkki Isometsä
Journal:  J Affect Disord       Date:  2008-04-28       Impact factor: 4.839

Review 9.  Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.

Authors:  Abraham Reichenberg; Philip D Harvey
Journal:  Psychol Bull       Date:  2007-09       Impact factor: 17.737

10.  Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats.

Authors:  D A Slattery; I D Neumann
Journal:  Neuropharmacology       Date:  2009-07-07       Impact factor: 5.250

View more
  1 in total

1.  Clinical and genetic validity of quantitative bipolarity.

Authors:  Heather A Bruce; Peter Kochunov; Braxton Mitchell; Kevin A Strauss; Seth A Ament; Laura M Rowland; Xiaoming Du; Feven Fisseha; Thangavelu Kavita; Joshua Chiappelli; Krista Wisner; Hemalatha Sampath; Shuo Chen; Mark D Kvarta; Chamindi Seneviratne; Teodor T Postolache; Alfredo Bellon; Francis J McMahon; Alan Shuldiner; L Elliot Hong
Journal:  Transl Psychiatry       Date:  2019-09-16       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.